Status:
RECRUITING
Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
18+ years
Brief Summary
This is a prospective data registry to assess the treatment outcomes and complications of different treatment approaches in our hospital clusters.
Detailed Description
Benign prostatic hyperplasia (BPH) is a very common disease affecting men. Patients with BPH may present with voiding symptoms including hesitancy, intermittence, slow stream and sensation of incomple...
Eligibility Criteria
Inclusion
- Patient at the age of 18 or above
Exclusion
- Patient is unable to give consent
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2032
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05292235
Start Date
April 1 2022
End Date
July 31 2032
Last Update
May 6 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Alice Ho Miu Ling Nethersole Hospital
Hong Kong, Hong Kong
2
North District Hospital
Hong Kong, Hong Kong
3
Prince of Wales Hospital
Shatin, Hong Kong